Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | euchromatic histone-lysine N-methyltransferase 2 | Starlite/ChEMBL | No references |
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.0183 | 0.6134 | 0.7666 |
Echinococcus multilocularis | geminin | 0.0183 | 0.6134 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0094 | 0.2828 | 0.3535 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0018 | 0 | 0.5 |
Brugia malayi | Pre-SET motif family protein | 0.0251 | 0.8703 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0039 | 0.076 | 0.0949 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0039 | 0.076 | 0.1238 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0039 | 0.076 | 0.1238 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0036 | 0.0658 | 0.0823 |
Schistosoma mansoni | histone-lysine n-methyltransferase suv9 | 0.0036 | 0.0658 | 0.0823 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0039 | 0.076 | 0.0949 |
Plasmodium vivax | dipeptidyl aminopeptidase 2, putative | 0.0233 | 0.8001 | 1 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0094 | 0.2828 | 0.325 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0036 | 0.0658 | 0.1073 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0018 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0018 | 0 | 0.5 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0018 | 0 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0094 | 0.2828 | 0.4611 |
Schistosoma mansoni | dipeptidyl-peptidase I (C01 family) | 0.0233 | 0.8001 | 1 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0251 | 0.8703 | 1 |
Echinococcus granulosus | geminin | 0.0183 | 0.6134 | 1 |
Toxoplasma gondii | preprocathepsin c precursor, putative | 0.0233 | 0.8001 | 1 |
Plasmodium falciparum | dipeptidyl aminopeptidase 1 | 0.0233 | 0.8001 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0036 | 0.0658 | 0.0823 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0018 | 0 | 0.5 |
Trichomonas vaginalis | set domain proteins, putative | 0.0286 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0039 | 0.076 | 1 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0018 | 0 | 0.5 |
Echinococcus multilocularis | histone lysine N methyltransferase SETMAR | 0.0036 | 0.0658 | 0.1073 |
Plasmodium falciparum | dipeptidyl aminopeptidase 2 | 0.0233 | 0.8001 | 1 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin B-like cysteine peptidase | 0.0233 | 0.8001 | 0.8001 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.0658 | 0.0756 |
Brugia malayi | hypothetical protein | 0.0039 | 0.076 | 0.0873 |
Plasmodium vivax | SET domain protein, putative | 0.0036 | 0.0658 | 0.0823 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0094 | 0.2828 | 0.3535 |
Entamoeba histolytica | hypothetical protein | 0.0039 | 0.076 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0036 | 0.0658 | 0.0823 |
Plasmodium vivax | dipeptidyl aminopeptidase 1, putative | 0.0233 | 0.8001 | 1 |
Brugia malayi | Pre-SET motif family protein | 0.0036 | 0.0658 | 0.0756 |
Toxoplasma gondii | cathepsin CPC1 | 0.0233 | 0.8001 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0039 | 0.076 | 1 |
Echinococcus granulosus | 5'partial|histone lysine N methyltransferase SETDB2 | 0.0035 | 0.0608 | 0.0992 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0036 | 0.0658 | 0.1073 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0094 | 0.2828 | 0.325 |
Schistosoma mansoni | hypothetical protein | 0.0183 | 0.6134 | 0.7666 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0094 | 0.2828 | 0.3535 |
Toxoplasma gondii | histone lysine methyltransferase SET/SUV39 | 0.0036 | 0.0658 | 0.0823 |
Entamoeba histolytica | hypothetical protein | 0.0039 | 0.076 | 1 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0018 | 0 | 0.5 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0018 | 0 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0094 | 0.2828 | 0.4611 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0094 | 0.2828 | 0.4611 |
Giardia lamblia | Dipeptidyl-peptidase I precursor | 0.0233 | 0.8001 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0094 | 0.2828 | 0.4611 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 1.9953 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 3.5481 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 37.933 uM | PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.